General KALYDECO project information

Last updated: 2022-04-12 16:33

Project name

Evaluation of the new medication Kalydeco to treat cystic fibrosis

Project abbreviation


Project code


Primary organization that oversees implementation of project

  • Vertex Pharmaceuticals

Partner organization participating in project

  • Not available

Organisation that commissioned this project

  • National Institute for Health and Disability Insurance (RIZIV-INAMI)

Organisation providing monetary or material support

  • Vertex Pharmaceuticals

Brief project description

Not available

Regulatory framework of this project

Consult the regulatory framework information published on the pages.